Specialty Pharma ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Specialty Pharma ApS
Specialty Pharma ApS (CVR number: 38476599) is a company from RUDERSDAL. The company recorded a gross profit of 96.4 kDKK in 2024. The operating profit was -60.7 kDKK, while net earnings were -53.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -35.9 %, which can be considered poor and Return on Equity (ROE) was -79.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 25.8 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Specialty Pharma ApS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 943.77 | 639.30 | 1 023.44 | 292.69 | 96.40 |
EBIT | -39.42 | -65.47 | 59.94 | 108.94 | -60.66 |
Net earnings | -39.45 | -44.23 | 41.13 | 80.69 | -53.76 |
Shareholders equity total | 16.92 | -27.31 | 13.82 | 94.51 | 40.75 |
Balance sheet total (assets) | 179.46 | 123.59 | 115.78 | 180.33 | 157.69 |
Net debt | - 105.94 | - 101.85 | -94.34 | -52.07 | -52.18 |
Profitability | |||||
EBIT-% | |||||
ROA | -25.8 % | -39.6 % | 45.0 % | 73.6 % | -35.9 % |
ROE | -107.7 % | -63.0 % | 59.9 % | 149.0 % | -79.5 % |
ROI | -107.6 % | -773.9 % | 867.7 % | 201.1 % | -89.7 % |
Economic value added (EVA) | -42.26 | -44.75 | 43.70 | 80.00 | -56.39 |
Solvency | |||||
Equity ratio | 9.4 % | -18.1 % | 11.9 % | 52.4 % | 25.8 % |
Gearing | |||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.1 | 0.8 | 1.1 | 2.1 | 1.3 |
Current ratio | 1.1 | 0.8 | 1.1 | 2.1 | 1.3 |
Cash and cash equivalents | 105.94 | 101.85 | 94.34 | 52.07 | 52.18 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | B | BB | BB |
Variable visualization
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.